These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4006483)

  • 21. Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience.
    Hawkins CM; Richardson DW; Vokonas PS
    Circulation; 1983 Jun; 67(6 Pt 2):I94-7. PubMed ID: 6342843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Beta-Blocker Heart Attack Trial in perspective.
    Goldstein S
    Cardiology; 1983; 70(5):255-62. PubMed ID: 6141847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic beta blockade therapy in patients after myocardial infarction.
    Pratt CM; Roberts R
    Am J Cardiol; 1983 Oct; 52(7):661-4. PubMed ID: 6137945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression.
    Shivkumar K; Schultz L; Goldstein S; Gheorghiade M
    Am Heart J; 1998 Feb; 135(2 Pt 1):261-7. PubMed ID: 9489974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.
    Hansteen V
    Circulation; 1983 Jun; 67(6 Pt 2):I57-60. PubMed ID: 6342841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival analysis of adverse effects data in the Beta-Blocker Heart Attack Trial.
    Davis BR; Furberg CD; Williams CB
    Clin Pharmacol Ther; 1987 Jun; 41(6):611-5. PubMed ID: 3555942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: the Beta-Blocker Heart Attack Trial experience.
    Byington RP; Worthy J; Craven T; Furberg CD
    Am J Cardiol; 1990 Jun; 65(20):1287-91. PubMed ID: 2188492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A coordinating center in a clinical trial: the Hypertension Detection and Followup Program.
    Curb JD; Ford C; Hawkins CM; Smith EO; Zimbaldi N; Carter B; Cooper C
    Control Clin Trials; 1983 Sep; 4(3):171-86. PubMed ID: 6641231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience.
    Furberg CD; Byington RP
    Circulation; 1983 Jun; 67(6 Pt 2):I98-101. PubMed ID: 6133654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Publicity on the beta-blocker heart attack trial (continued).
    Frommer PL
    N Engl J Med; 1982 Jun; 306(25):1553-4. PubMed ID: 6123081
    [No Abstract]   [Full Text] [Related]  

  • 31. Addition of Propranolol in Resistant Arterial hypertension Treatment (APROPRIATE study): study protocol for a randomized double-blind placebo-controlled trial.
    Constantine GR; Ranasinghe P; Weeratunga P; Weeraratne C; Galappatthy P; Rajapakse S; Senarath U; Katulanda P
    Trials; 2017 Mar; 18(1):124. PubMed ID: 28292320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of the long-term controlled trials of usefulness of therapy for systemic hypertension.
    Gifford RW
    Am J Cardiol; 1989 Jan; 63(4):8B-16B. PubMed ID: 2563189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Norwegian propranolol trial in selected patients.
    Hansteen V
    Br J Clin Pharmacol; 1982; 14 Suppl 1(Suppl 1):9S-12S. PubMed ID: 7052112
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
    Otterstad JE; Ford I
    Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-blockers vs. thiazides in the treatment of hypertension: a review of the experience of the large national trials.
    Miall WE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S58-63. PubMed ID: 11527138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propranolol and the morning increase in sudden cardiac death: (the beta-blocker heart attack trial experience).
    Peters RW
    Am J Cardiol; 1990 Nov; 66(16):57G-59G. PubMed ID: 2239715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-blocker prophylaxis after myocardial infarction.
    S Afr Med J; 1981 Jun; 59(24):845-6. PubMed ID: 7015532
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypertension: possible differential risk for blacks in Beta-Blocker Heart Attack Trial (BHAT).
    Haywood LJ
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):865-8. PubMed ID: 2574045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship of treatment adherence to the risk of death after myocardial infarction in women.
    Gallagher EJ; Viscoli CM; Horwitz RI
    JAMA; 1993 Aug; 270(6):742-4. PubMed ID: 8336377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment adherence and risk of death after a myocardial infarction.
    Horwitz RI; Viscoli CM; Berkman L; Donaldson RM; Horwitz SM; Murray CJ; Ransohoff DF; Sindelar J
    Lancet; 1990 Sep; 336(8714):542-5. PubMed ID: 1975045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.